NCT04613817View on ClinicalTrials.gov

Sero-prevalence COVID-19 Among Belgian Children

CompletedOBSERVATIONAL
Enrollment

2,103

Participants

Timeline

Start Date

December 3, 2020

Primary Completion Date

December 17, 2021

Study Completion Date

December 31, 2021

Conditions
SARS-CoV-2SARS-CoV InfectionCovid19
Trial Locations (1)

1050

Sciensano, Brussels

All Listed Sponsors
collaborator

KU Leuven

OTHER

collaborator

McGill University

OTHER

lead

Sciensano

OTHER_GOV

NCT04613817 - Sero-prevalence COVID-19 Among Belgian Children | Biotech Hunter | Biotech Hunter